DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $70,829,741 | +5.7% | 285,489 | +2.2% | 0.07% | +13.3% |
Q2 2023 | $67,026,370 | -32.3% | 279,277 | -28.9% | 0.06% | -36.8% |
Q1 2023 | $99,028,549 | -5.0% | 392,908 | +0.0% | 0.10% | -7.8% |
Q4 2022 | $104,284,451 | +3.4% | 392,904 | +0.7% | 0.10% | +1.0% |
Q3 2022 | $100,809,000 | +6.7% | 390,295 | +4.8% | 0.10% | +15.9% |
Q2 2022 | $94,437,000 | -1.0% | 372,503 | +14.5% | 0.09% | +22.2% |
Q1 2022 | $95,428,000 | -5.1% | 325,326 | +6.4% | 0.07% | +4.3% |
Q4 2021 | $100,583,000 | +5.8% | 305,714 | -2.1% | 0.07% | +1.5% |
Q3 2021 | $95,075,000 | +26.4% | 312,296 | +11.4% | 0.07% | +30.8% |
Q2 2021 | $75,234,000 | +30.7% | 280,349 | +9.7% | 0.05% | +20.9% |
Q1 2021 | $57,542,000 | +29.7% | 255,651 | +28.0% | 0.04% | +26.5% |
Q4 2020 | $44,359,000 | +3.9% | 199,691 | +0.7% | 0.03% | -8.1% |
Q3 2020 | $42,680,000 | +26.2% | 198,205 | +3.7% | 0.04% | +19.4% |
Q2 2020 | $33,806,000 | +41.6% | 191,180 | +10.8% | 0.03% | +19.2% |
Q1 2020 | $23,878,000 | -12.0% | 172,516 | -1.4% | 0.03% | +18.2% |
Q4 2019 | $27,138,000 | +23.3% | 174,962 | +14.8% | 0.02% | +15.8% |
Q3 2019 | $22,018,000 | +5.9% | 152,450 | +4.8% | 0.02% | +5.6% |
Q2 2019 | $20,794,000 | +42.3% | 145,492 | +31.4% | 0.02% | +38.5% |
Q1 2019 | $14,615,000 | +36.8% | 110,701 | +6.8% | 0.01% | +18.2% |
Q4 2018 | $10,685,000 | -1.4% | 103,620 | +3.9% | 0.01% | +22.2% |
Q3 2018 | $10,841,000 | -0.4% | 99,771 | -9.6% | 0.01% | 0.0% |
Q2 2018 | $10,887,000 | -1.5% | 110,329 | -2.2% | 0.01% | -10.0% |
Q1 2018 | $11,051,000 | +6.0% | 112,867 | +0.5% | 0.01% | 0.0% |
Q4 2017 | $10,428,000 | +9.0% | 112,346 | +0.7% | 0.01% | +11.1% |
Q3 2017 | $9,571,000 | +6.2% | 111,572 | +4.4% | 0.01% | 0.0% |
Q2 2017 | $9,016,000 | +21.5% | 106,839 | +23.2% | 0.01% | +28.6% |
Q1 2017 | $7,420,000 | +331.4% | 86,750 | +292.6% | 0.01% | +250.0% |
Q4 2016 | $1,720,000 | -4.1% | 22,099 | -3.4% | 0.00% | 0.0% |
Q3 2016 | $1,794,000 | -1.9% | 22,886 | +26.5% | 0.00% | 0.0% |
Q2 2016 | $1,828,000 | +23.5% | 18,096 | +16.0% | 0.00% | 0.0% |
Q1 2016 | $1,480,000 | -0.9% | 15,599 | -3.0% | 0.00% | 0.0% |
Q4 2015 | $1,493,000 | +15.8% | 16,074 | +6.3% | 0.00% | 0.0% |
Q3 2015 | $1,289,000 | +9.3% | 15,125 | +9.8% | 0.00% | +100.0% |
Q2 2015 | $1,179,000 | +15.2% | 13,770 | +14.3% | 0.00% | 0.0% |
Q1 2015 | $1,023,000 | +6.8% | 12,049 | +7.8% | 0.00% | 0.0% |
Q4 2014 | $958,000 | +24.7% | 11,181 | +10.7% | 0.00% | 0.0% |
Q3 2014 | $768,000 | +1.3% | 10,102 | +5.0% | 0.00% | 0.0% |
Q2 2014 | $758,000 | +13.1% | 9,624 | +7.7% | 0.00% | 0.0% |
Q1 2014 | $670,000 | -1.8% | 8,939 | +1.2% | 0.00% | 0.0% |
Q4 2013 | $682,000 | +4.3% | 8,835 | -6.3% | 0.00% | 0.0% |
Q3 2013 | $654,000 | +16.0% | 9,428 | +6.0% | 0.00% | 0.0% |
Q2 2013 | $564,000 | – | 8,895 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |